Global Non Insulin Anti diabetes Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: GCE17DC193FCEN
QYResearch

Abstracts

This report focuses on the global Non Insulin Anti diabetes Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non Insulin Anti diabetes Drugs development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Sanofi
• Abbott
• AstraZeneca
• Eli Lilly
• Roche
• GlaxoSmithKline
• Johnson & Johnson
• Novartis

Market segment by Type, the product can be split into

• Oral Drugs
• Injectable Drugs

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Non Insulin Anti diabetes Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Non Insulin Anti diabetes Drugs development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Non Insulin Anti diabetes Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non Insulin Anti diabetes Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Non Insulin Anti diabetes Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral Drugs
  1.4.3 Injectable Drugs
1.5 Market by Application
  1.5.1 Global Non Insulin Anti diabetes Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Non Insulin Anti diabetes Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Non Insulin Anti diabetes Drugs Industry
    1.6.1.1 Non Insulin Anti diabetes Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Non Insulin Anti diabetes Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Non Insulin Anti diabetes Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Non Insulin Anti diabetes Drugs Market Perspective (2015-2026)
2.2 Non Insulin Anti diabetes Drugs Growth Trends by Regions
  2.2.1 Non Insulin Anti diabetes Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Non Insulin Anti diabetes Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Non Insulin Anti diabetes Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Non Insulin Anti diabetes Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Non Insulin Anti diabetes Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Non Insulin Anti diabetes Drugs Players by Market Size
  3.1.1 Global Top Non Insulin Anti diabetes Drugs Players by Revenue (2015-2020)
  3.1.2 Global Non Insulin Anti diabetes Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Non Insulin Anti diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non Insulin Anti diabetes Drugs Market Concentration Ratio
  3.2.1 Global Non Insulin Anti diabetes Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Non Insulin Anti diabetes Drugs Revenue in 2019
3.3 Non Insulin Anti diabetes Drugs Key Players Head office and Area Served
3.4 Key Players Non Insulin Anti diabetes Drugs Product Solution and Service
3.5 Date of Enter into Non Insulin Anti diabetes Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Non Insulin Anti diabetes Drugs Historic Market Size by Type (2015-2020)
4.2 Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Type (2021-2026)

5 NON INSULIN ANTI DIABETES DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020)
5.2 Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Non Insulin Anti diabetes Drugs Market Size (2015-2020)
6.2 Non Insulin Anti diabetes Drugs Key Players in North America (2019-2020)
6.3 North America Non Insulin Anti diabetes Drugs Market Size by Type (2015-2020)
6.4 North America Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Non Insulin Anti diabetes Drugs Market Size (2015-2020)
7.2 Non Insulin Anti diabetes Drugs Key Players in Europe (2019-2020)
7.3 Europe Non Insulin Anti diabetes Drugs Market Size by Type (2015-2020)
7.4 Europe Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size (2015-2020)
8.2 Non Insulin Anti diabetes Drugs Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type (2015-2020)
8.4 Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Sanofi
  9.1.1 Sanofi Company Details
  9.1.2 Sanofi Business Overview and Its Total Revenue
  9.1.3 Sanofi Non Insulin Anti diabetes Drugs Introduction
  9.1.4 Sanofi Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020))
  9.1.5 Sanofi Recent Development
9.2 Abbott
  9.2.1 Abbott Company Details
  9.2.2 Abbott Business Overview and Its Total Revenue
  9.2.3 Abbott Non Insulin Anti diabetes Drugs Introduction
  9.2.4 Abbott Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020)
  9.2.5 Abbott Recent Development
9.3 AstraZeneca
  9.3.1 AstraZeneca Company Details
  9.3.2 AstraZeneca Business Overview and Its Total Revenue
  9.3.3 AstraZeneca Non Insulin Anti diabetes Drugs Introduction
  9.3.4 AstraZeneca Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020)
  9.3.5 AstraZeneca Recent Development
9.4 Eli Lilly
  9.4.1 Eli Lilly Company Details
  9.4.2 Eli Lilly Business Overview and Its Total Revenue
  9.4.3 Eli Lilly Non Insulin Anti diabetes Drugs Introduction
  9.4.4 Eli Lilly Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020)
  9.4.5 Eli Lilly Recent Development
9.5 Roche
  9.5.1 Roche Company Details
  9.5.2 Roche Business Overview and Its Total Revenue
  9.5.3 Roche Non Insulin Anti diabetes Drugs Introduction
  9.5.4 Roche Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020)
  9.5.5 Roche Recent Development
9.6 GlaxoSmithKline
  9.6.1 GlaxoSmithKline Company Details
  9.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.6.3 GlaxoSmithKline Non Insulin Anti diabetes Drugs Introduction
  9.6.4 GlaxoSmithKline Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020)
  9.6.5 GlaxoSmithKline Recent Development
9.7 Johnson & Johnson
  9.7.1 Johnson & Johnson Company Details
  9.7.2 Johnson & Johnson Business Overview and Its Total Revenue
  9.7.3 Johnson & Johnson Non Insulin Anti diabetes Drugs Introduction
  9.7.4 Johnson & Johnson Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020)
  9.7.5 Johnson & Johnson Recent Development
9.8 Novartis
  9.8.1 Novartis Company Details
  9.8.2 Novartis Business Overview and Its Total Revenue
  9.8.3 Novartis Non Insulin Anti diabetes Drugs Introduction
  9.8.4 Novartis Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020)
  9.8.5 Novartis Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Non Insulin Anti diabetes Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Non Insulin Anti diabetes Drugs Revenue
Table 3. Ranking of Global Top Non Insulin Anti diabetes Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non Insulin Anti diabetes Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Drugs
Table 6. Key Players of Injectable Drugs
Table 7. COVID-19 Impact Global Market: (Four Non Insulin Anti diabetes Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Non Insulin Anti diabetes Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Non Insulin Anti diabetes Drugs Players to Combat Covid-19 Impact
Table 12. Global Non Insulin Anti diabetes Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Non Insulin Anti diabetes Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Non Insulin Anti diabetes Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Non Insulin Anti diabetes Drugs Market Share by Regions (2015-2020)
Table 16. Global Non Insulin Anti diabetes Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Non Insulin Anti diabetes Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Non Insulin Anti diabetes Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Non Insulin Anti diabetes Drugs Players
Table 23. Global Non Insulin Anti diabetes Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Non Insulin Anti diabetes Drugs Market Share by Players (2015-2020)
Table 25. Global Top Non Insulin Anti diabetes Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Insulin Anti diabetes Drugs as of 2019)
Table 26. Global Non Insulin Anti diabetes Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Non Insulin Anti diabetes Drugs Product Solution and Service
Table 29. Date of Enter into Non Insulin Anti diabetes Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Non Insulin Anti diabetes Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Non Insulin Anti diabetes Drugs Market Size Share by Type (2015-2020)
Table 33. Global Non Insulin Anti diabetes Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Non Insulin Anti diabetes Drugs Market Size Share by Application (2015-2020)
Table 35. Global Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Non Insulin Anti diabetes Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Non Insulin Anti diabetes Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Non Insulin Anti diabetes Drugs Market Share (2019-2020)
Table 39. North America Non Insulin Anti diabetes Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Non Insulin Anti diabetes Drugs Market Share by Type (2015-2020)
Table 41. North America Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Non Insulin Anti diabetes Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Non Insulin Anti diabetes Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Non Insulin Anti diabetes Drugs Market Share (2019-2020)
Table 45. Europe Non Insulin Anti diabetes Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Non Insulin Anti diabetes Drugs Market Share by Type (2015-2020)
Table 47. Europe Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Non Insulin Anti diabetes Drugs Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Non Insulin Anti diabetes Drugs Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Non Insulin Anti diabetes Drugs Market Share (2019-2020)
Table 51. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Non Insulin Anti diabetes Drugs Market Share by Type (2015-2020)
Table 53. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Non Insulin Anti diabetes Drugs Market Share by Application (2015-2020)
Table 55. Sanofi Company Details
Table 56. Sanofi Business Overview
Table 57. Sanofi Product
Table 58. Sanofi Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 59. Sanofi Recent Development
Table 60. Abbott Company Details
Table 61. Abbott Business Overview
Table 62. Abbott Product
Table 63. Abbott Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 64. Abbott Recent Development
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Product
Table 68. AstraZeneca Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 69. AstraZeneca Recent Development
Table 70. Eli Lilly Company Details
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly Product
Table 73. Eli Lilly Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 74. Eli Lilly Recent Development
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Product
Table 78. Roche Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 79. Roche Recent Development
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 84. GlaxoSmithKline Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 89. Johnson & Johnson Recent Development
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Company Details
Table 93. Novartis Revenue in Non Insulin Anti diabetes Drugs Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Non Insulin Anti diabetes Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Drugs Features
Figure 3. Injectable Drugs Features
Figure 4. Global Non Insulin Anti diabetes Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Non Insulin Anti diabetes Drugs Report Years Considered
Figure 9. Global Non Insulin Anti diabetes Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Non Insulin Anti diabetes Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Non Insulin Anti diabetes Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Non Insulin Anti diabetes Drugs Market Share by Players in 2019
Figure 14. Global Top Non Insulin Anti diabetes Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Insulin Anti diabetes Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Non Insulin Anti diabetes Drugs Revenue in 2019
Figure 16. North America Non Insulin Anti diabetes Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Non Insulin Anti diabetes Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Non Insulin Anti diabetes Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. Sanofi Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 21. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Abbott Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 23. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AstraZeneca Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 25. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Eli Lilly Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Roche Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 29. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GlaxoSmithKline Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Non Insulin Anti diabetes Drugs Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed